Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,488 | 889 | 99.4% |
| Education | $85.20 | 15 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,634 | 164 | $0 (2024) |
| PFIZER INC. | $1,879 | 134 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,243 | 73 | $0 (2024) |
| Lilly USA, LLC | $1,006 | 60 | $0 (2024) |
| ABBVIE INC. | $990.18 | 61 | $0 (2024) |
| Amgen Inc. | $909.65 | 60 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $860.32 | 51 | $0 (2023) |
| Merck Sharp & Dohme LLC | $610.00 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $504.07 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $468.87 | 35 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $967.36 | 48 | Novo Nordisk Inc ($221.63) |
| 2023 | $1,527 | 87 | AbbVie Inc. ($371.51) |
| 2022 | $1,893 | 100 | Novo Nordisk Inc ($349.82) |
| 2021 | $2,506 | 142 | Novo Nordisk Inc ($405.41) |
| 2020 | $2,043 | 128 | PFIZER INC. ($385.19) |
| 2019 | $1,902 | 121 | Novo Nordisk Inc ($323.70) |
| 2018 | $1,921 | 144 | Novo Nordisk Inc ($454.10) |
| 2017 | $1,814 | 134 | Boehringer Ingelheim Pharmaceuticals, Inc. ($420.27) |
All Payment Transactions
904 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Durable Pump | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: Durable Pump | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: VACCINES | ||||||
| 08/26/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Durable Pump | ||||||
| 08/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Diabetes Care | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: VACCINES | ||||||
| 06/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: VACCINES | ||||||
| 05/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 646 | 826 | $195,403 | $59,521 |
| 2022 | 7 | 562 | 712 | $174,295 | $53,692 |
| 2021 | 10 | 821 | 1,006 | $223,207 | $68,974 |
| 2020 | 12 | 1,132 | 1,441 | $306,148 | $84,862 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 279 | $84,816 | $23,101 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 174 | 174 | $62,292 | $21,838 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 153 | $31,518 | $8,862 | 28.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 167 | 167 | $8,517 | $3,021 | 35.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $5,082 | $1,778 | 35.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 16 | $2,944 | $831.53 | 28.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 26 | $234.00 | $88.66 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 270 | $82,080 | $23,876 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 134 | 134 | $47,935 | $17,020 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 92 | $18,952 | $5,749 | 30.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 30 | 38 | $11,552 | $3,047 | 26.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 121 | 121 | $6,171 | $2,218 | 35.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 34 | 36 | $7,416 | $1,709 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 21 | $189.00 | $72.09 | 38.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 284 | $86,336 | $23,525 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 140 | 140 | $45,014 | $18,579 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 167 | 236 | $48,616 | $12,031 | 24.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 65 | 65 | $9,968 | $4,177 | 41.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 31 | 33 | $10,032 | $3,362 | 33.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 135 | 135 | $6,885 | $2,546 | 37.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 11 | 11 | $5,082 | $1,880 | 37.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $6,075 | $1,638 | 27.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 69 | 69 | $5,037 | $1,173 | 23.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 16 | 18 | $162.00 | $62.64 | 38.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 216 | 398 | $120,992 | $28,429 | 23.5% |
About Dr. Robert Duck, MD
Dr. Robert Duck, MD is a Family Medicine healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629160577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Duck, MD has received a total of $14,573 in payments from pharmaceutical and medical device companies, with $967.36 received in 2024. These payments were reported across 904 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($14,488).
As a Medicare-enrolled provider, Duck has provided services to 3,161 Medicare beneficiaries, totaling 3,985 services with total Medicare billing of $267,050. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Winchester, VA
- Active Since 09/29/2006
- Last Updated 03/23/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629160577
Products in Payments
- Ozempic (Drug) $1,174
- VRAYLAR (Drug) $932.85
- FARXIGA (Drug) $856.00
- Rybelsus (Drug) $399.61
- CHANTIX (Drug) $390.83
- Victoza (Drug) $390.57
- Aimovig (Biological) $376.64
- TRADJENTA (Drug) $359.78
- EMGALITY (Drug) $356.89
- XARELTO (Drug) $333.30
- ELIQUIS (Drug) $300.37
- TRULICITY (Drug) $296.35
- NEXLETOL (Drug) $262.06
- UBRELVY (Drug) $244.63
- JANUVIA (Drug) $204.37
- TRELEGY ELLIPTA (Drug) $199.77
- BELSOMRA (Drug) $197.68
- JARDIANCE (Drug) $196.50
- PREVNAR 20 (Biological) $195.93
- Prolia (Biological) $195.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Winchester
James Rider, D.o, D.O
Family Medicine — Payments: $110,589
Dr. Jordan Tran, M.d, M.D
Family Medicine — Payments: $40,472
Stephanie Hoefle, Md, MD
Family Medicine — Payments: $5,436
Patricia Houser
Family Medicine — Payments: $5,229
Michelle Carpenter, Do, DO
Family Medicine — Payments: $4,979
Charles Arnold, M.d, M.D
Family Medicine — Payments: $4,790